The Factors Affecting the Compliance of Additional Anticholinergic Medication in the Patients with Benign Prostatic Hyperplasia

Sang-Hoon KIM; Kyu-In JUNG; Su-Yeon CHO; Hyun-Woo KIM.
Journal of the Korean Continence Society ; : 45-50, 2009.
Artículo en Ko | WPRIM | ID: wpr-105940

Documentos relacionados

  1. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
  2. [PHYTOTHERAPY AND NATURAL AGENTS IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH)].
  3. [Effect of auricular acupressure combined with 5α-reductase inhibitor on short-term quality of life of patients after transurethral plasmakinetic enucleation of the prostate].
  4. Treatment of overactive bladder in men: Is it really different?
  5. How effectively do we apply first-line treatment in overactive bladder?
  6. [Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
  7. Potentially inappropriate prescriptions of anticholinergic drugs in patients with benign prostatic hyperplasia.
  8. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients - a network meta-analysis.
  9. Clinical guidelines for nocturia.
  10. Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting.